SCHEMBL21687601

SCHEMBL21687601

N#Cc1cc(-c2ccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3)cc2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PGR P06401 1/20 0.36
CYP19A1 P11511 2/20 0.35
PTGER4 P35408 1/20 0.34
RXRA P19793 1/20 0.33
RXRG P48443 1/20 0.33
METAP2 P50579 1/20 0.33
HDAC4 P56524 1/20 0.32
ADORA2A P29274 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
PDPK1 O15530 1/20 0.31
ALDH1A3 P47895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688017 0.94 PTGER4 (0.35) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL26940643 0.93 PTGER4 (0.35) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL21687598 0.92 KDM4E (0.39) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL21687668 0.90 PGR (0.35) KDM4EPGRCYP19A1PTGER4RXRA
SCHEMBL21687975 0.90 KDM4E (0.37) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL16299620 0.89 KDM4E (0.35) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL21687448 0.89 ATM (0.41) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL16299613 0.87 KDM4E (0.36) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL21688171 0.87 KDM4E (0.35) ATMKDM4EL3MBTL1PGRCYP19A1
SCHEMBL18715205 0.86 KDM4E (0.46) ATMKDM4EL3MBTL1PGRCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 ATM 1151/4885KDM4E 2977/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 ATM 1151/4885KDM4E 2977/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.